{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06273891",
            "orgStudyIdInfo": {
                "id": "INOVA-2023-58"
            },
            "secondaryIdInfos": [
                {
                    "id": "23-08-WC-0198",
                    "type": "OTHER",
                    "domain": "Eastern Virginia Medical School"
                }
            ],
            "organization": {
                "fullName": "Inova Fairfax Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes",
            "officialTitle": "Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes: A Cluster Randomized Comparative Effectiveness Trial",
            "acronym": "PRACET",
            "therapeuticArea": [
                "Other"
            ],
            "study": "erythromycin-versus-azithromycin-for-preterm-prelabor-rupture-of-membranes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-14",
            "studyFirstSubmitQcDate": "2024-02-20",
            "studyFirstPostDateStruct": {
                "date": "2024-02-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Antonio Saad",
                "investigatorTitle": "Director of Perinatal Research Unit",
                "investigatorAffiliation": "Inova Fairfax Hospital"
            },
            "leadSponsor": {
                "name": "Inova Fairfax Hospital",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Eastern Virginia Medical School",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to help identify the best antibiotic treatment for pregnant people when their water breaks prematurely (a condition abbreviated as PPROM). Current practice is to attempt to maintain the pregnancy until at least 34 weeks gestational age, when the risks of prematurity to the baby are lessened. Research shows that antibiotics help the pregnancy last longer, but there have been limited studies about which combination works best. Currently, both azithromycin and erythromycin are accepted antibiotic treatments, in addition to ampicillin and amoxicillin. Participants diagnosed with PPROM will be randomized to receive ampicillin and amoxicillin plus either azithromycin or erythromycin, in addition to the care they would normally receive. Studying these two drugs will help decide the best care for future patients with PPROM.",
            "detailedDescription": "Preterm pre-labor rupture of membranes (PPROM) complicates 3% of pregnancies and accounts for one-fourth to one-third of preterm births. PPROM is associated with significant maternal and neonatal morbidities, including chorioamnionitis, endometritis, neonatal sepsis, prematurity-related pathologies. In the absence of labor or indication for immediate delivery, patients who present at less than 34 weeks gestational age are treated with antibiotics to prolong pregnancy until 34 weeks when the risks of prematurity are decreased. Based on randomized trials, both the American College of Obstetrics and Gynecology (ACOG) and the Society of Maternal Fetal Medicine (SMFM) recommend IV ampicillin and IV erythromycin for 2 days, followed by an oral regimen of amoxicillin and erythromycin for 5 days. Due to the recent limited availability of erythromycin, azithromycin has been used a substitute. There have been observational studies showing no difference in duration of pregnancy between azithromycin and erythromycin, however no randomized controlled trial has been carried out to our knowledge. This study performs a cluster randomized controlled trial to examine the efficacy of azithromycin versus erythromycin as a component of the \"latency antibiotics\" used to prolong pregnancy in PPROM patients."
        },
        "conditionsModule": {
            "conditions": [
                "Premature Rupture of Membrane"
            ],
            "keywords": [
                "pprom",
                "latency antibiotics",
                "prom"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Erythromycin",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Erythromycin 250 mg IV every 6 hours for 48 hours, followed by 250 mg PO or 333 mg PO every 8 hours for 5 days",
                    "interventionNames": [
                        "Drug: Erythromycin"
                    ]
                },
                {
                    "label": "Azithromycin",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Azithromycin 1 gm PO once or 500 mg PO followed by 250 mg PO daily for a total of 5 days",
                    "interventionNames": [
                        "Drug: Azithromycin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Erythromycin",
                    "description": "Erythromycin 250 mg IV every 6 hours for 48 hours, followed by 250 mg PO or 333 mg PO every 8 hours for 5 days\n\nin addition to Ampicillin 2 gm IV every 6 hours for 2 days followed by Amoxicillin 250 mg PO every 8 hours for 5 days",
                    "armGroupLabels": [
                        "Erythromycin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Azithromycin",
                    "description": "Azithromycin 1 gm PO once or 500 mg PO followed by 250 mg PO daily for a total of 5 days\n\nin addition to Ampicillin 2 gm IV every 6 hours for 2 days followed by Amoxicillin 250 mg PO every 8 hours for 5 days",
                    "armGroupLabels": [
                        "Azithromycin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Latency period",
                    "description": "Time from PPROM to delivery between the two treatments",
                    "timeFrame": "Number of days from PPROM to delivery, assessed up to 105 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Pregnancy at 22 weeks 0 days to 32 weeks 6 days of gestation.\n* Rupture of membranes confirmed by biochemical testing.\n* Membrane rupture within the past 36 hours.\n* Cervical dilation 3 cm or less and 4 or fewer contractions within 60-minutes at the time of admission.\n* Age \u226518 and \\<50 years.\n\nExclusion Criteria:\n\n* Non-reassuring fetal heart tracing, vaginal bleeding, chorioamnionitis or any indication for delivery at admission.\n* Allergy to penicillin, erythromycin, or azithromycin.\n* Multiple gestations.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Antonio Saad, MD, MBA",
                    "role": "CONTACT",
                    "phone": "7037766040",
                    "email": "antonio.saad@inova.org"
                },
                {
                    "name": "Ellen M Murrin, DO",
                    "role": "CONTACT",
                    "phone": "7037766040",
                    "email": "ellen.murrin@inova.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Antonio Saad, MD, MBA",
                    "affiliation": "Inova Health Systems",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Ellen M Murrin, DO",
                    "affiliation": "Inova Health Systems",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Inova Fairfax Medical Campus",
                    "status": "RECRUITING",
                    "city": "Falls Church",
                    "state": "Virginia",
                    "zip": "22042",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ellen M Murrin, DO",
                            "role": "CONTACT",
                            "phone": "703-776-6040",
                            "email": "ellen.murrin@inova.org"
                        },
                        {
                            "name": "Antonio Saad, MD, MBA",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Ellen M Murrin, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.88233,
                        "lon": -77.17109
                    }
                },
                {
                    "facility": "Eastern Viriginia Medical School",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23507",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tetsuya Kawakita, MD",
                            "role": "CONTACT",
                            "phone": "757-446-7900",
                            "email": "kawakit@evms.edu"
                        },
                        {
                            "name": "Kristin Ayers, MPH",
                            "role": "CONTACT",
                            "phone": "7574460579",
                            "email": "ayerskl@evms.edu"
                        },
                        {
                            "name": "Tetsuya Kawakita, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "30904320",
                    "type": "BACKGROUND",
                    "citation": "Navathe R, Schoen CN, Heidari P, Bachilova S, Ward A, Tepper J, Visintainer P, Hoffman MK, Smith S, Berghella V, Roman A. Azithromycin vs erythromycin for the management of preterm premature rupture of membranes. Am J Obstet Gynecol. 2019 Aug;221(2):144.e1-144.e8. doi: 10.1016/j.ajog.2019.03.009. Epub 2019 Mar 20."
                },
                {
                    "pmid": "27245741",
                    "type": "BACKGROUND",
                    "citation": "Drassinower D, Friedman AM, Obican SG, Levin H, Gyamfi-Bannerman C. Prolonged latency of preterm prelabour rupture of membranes and neurodevelopmental outcomes: a secondary analysis. BJOG. 2016 Sep;123(10):1629-35. doi: 10.1111/1471-0528.14133. Epub 2016 May 31."
                },
                {
                    "pmid": "32080050",
                    "type": "BACKGROUND",
                    "citation": "Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol. 2020 Mar;135(3):e80-e97. doi: 10.1097/AOG.0000000000003700."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005322",
                    "term": "Fetal Membranes, Premature Rupture"
                },
                {
                    "id": "D000012421",
                    "term": "Rupture"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                },
                {
                    "id": "D000007744",
                    "term": "Obstetric Labor Complications"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M25869",
                    "name": "Premature Birth",
                    "relevance": "LOW"
                },
                {
                    "id": "M15241",
                    "name": "Rupture",
                    "asFound": "Rupture",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8452",
                    "name": "Fetal Membranes, Premature Rupture",
                    "asFound": "Premature Rupture of Membranes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M10764",
                    "name": "Obstetric Labor Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017963",
                    "term": "Azithromycin"
                },
                {
                    "id": "D000004917",
                    "term": "Erythromycin"
                },
                {
                    "id": "D000004918",
                    "term": "Erythromycin Estolate"
                },
                {
                    "id": "D000015643",
                    "term": "Erythromycin Ethylsuccinate"
                },
                {
                    "id": "C000011462",
                    "term": "Erythromycin stearate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000011500",
                    "term": "Protein Synthesis Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3995",
                    "name": "Amoxicillin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M4003",
                    "name": "Ampicillin",
                    "relevance": "LOW"
                },
                {
                    "id": "M20132",
                    "name": "Azithromycin",
                    "asFound": "Fasting",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8068",
                    "name": "Erythromycin",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8069",
                    "name": "Erythromycin Estolate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18236",
                    "name": "Erythromycin Ethylsuccinate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M195803",
                    "name": "Erythromycin stearate",
                    "asFound": "Proof of Concept Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}